top of page

'In the crosshairs': PBM reform effort intensifies on Capitol Hill

The drumbeat of calls to enact reforms to pharmaceutical middlemen is growing louder after years of largely unsuccessful attempts by lawmakers to make sweeping changes to how the industry operates — and advocates hope that conditions are ripe this year for action.


bottom of page